Chronic liver disease in aboriginal north Americans

World Journal of Gastroenterology

Volumn 14, Issue 29, 2008, Pages 4607-4615

  Scott, John D ^a   Garland, Naomi ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alaska Native; American Indian; Chronic liver disease; Hepatitis B virus; Hepatitis C virus

Indexed keywords

ABORIGINE; ALCOHOL LIVER DISEASE; AMERICAN INDIAN; AUTOIMMUNE HEPATITIS; CANADA; CAUSE OF DEATH; CHRONIC LIVER DISEASE; DELTA AGENT HEPATITIS; GEOGRAPHIC DISTRIBUTION; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HEREDITY; HUMAN; INCIDENCE; LITERATURE; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; PRIMARY BILIARY CIRRHOSIS; REVIEW; TREATMENT INDICATION; UNITED STATES; VIRUS HEPATITIS; CHRONIC DISEASE; ETHNOLOGY; LIVER DISEASE; NORTH AMERICA; PREVALENCE;

CHRONIC DISEASE; HEPATITIS C; HUMANS; INDIANS, NORTH AMERICAN; LIVER DISEASES; LIVER DISEASES, ALCOHOLIC; NORTH AMERICA; PREVALENCE;

EID: 58149180258     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4607     Document Type: Review

References (71)

1. US Department of Health and Human Services (Indian Health Service). Trends in Indian Health, 2000-2001. Accessed Mar 1, 2008. Available from: URL: http://www.ihs.gov/NonMedicalPrograms/IHS_Stats/ Trends00.asp
2. Mao Y, Morrison H, Semenciw R, Wigle D. Mortality on Canadian Indian Reserves 1977-1982. Can J Public Health 1986; 77: 263-268
3. Skinhoj P. Hepatitis and hepatitis B-antigen in Greenland. II: Occurrence and interrelation of hepatitis B associated surface, core, and "e" antigen-antibody systems in a highly endemic area. Am J Epidemiol 1977; 105: 99-106
4. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 2004; 39: 476-483
5. Castor ML, Smyser MS, Taualii MM, Park AN, Lawson SA, Forquera RA. A nationwide population-based study identifying health disparities between American Indians/Alaska Natives and the general populations living in select urban counties. Am J Public Health 2006; 96: 1478-1484
6. Bialek SR, Redd JT, Lynch A, Vogt TM, Lewis S, Wilson C, Bell BP. Chronic liver disease among two American Indian patient populations in the Southwestern United States, 2000-2003. J Clin Gastroenterol 2008; In press
7. Fischer G, Bialek SR, Homan C, Livingston S, McMahon BJ. Chronic liver disease among Alaska Native people, 2003-2004. Hepatology 2007; 46 Suppl 1: S895-S896
8. Desai S, Peltekian KM. Canadian mortality rates for liver disease: taking a closer look at ICD coding. Can J Public Health 2004; 95: 198-200
9. Rokkjaer MS, Jensen MT, Gronbaek H, Jepsen P, Pedersen HS, Vilstrup H. Discharge diagnoses of liver diseases in Nuuk Greenland compared to a Danish county hospital. Int J Circumpolar Health 2006; 65: 162-168
10. Welty TK, Darling K, Dye S, Lance S, Volmer L, Cheek J, Shapiro CN, Bell BP, Margolis HS. Guidelines for prevention and control of hepatitis A in American Indian and Alaska Native communities. S D J Med 1996; 49: 317-322
11. Williams R. Prevalence of hepatitis A virus antibody among Navajo school children. Am J Public Health 1986; 76: 282-283
12. Bulkow LR, Wainwright RB, McMahon BJ, Middaugh JP, Jenkerson SA, Margolis HS. Secular trends in hepatitis A virus infection among Alaska Natives. J Infect Dis 1993; 168: 1017-1020
13. Grossman DC, Krieger JW, Sugarman JR, Forquera RA. Health status of urban American Indians and Alaska Natives. A population-based study. JAMA 1994; 271: 845-850
14. Bialek SR, Thoroughman DA, Hu D, Simard EP, Chattin J, Cheek J, Bell BP. Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001. Am J Public Health 2004; 94: 996-1001
15. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 1996; 150: 733-739
16. Minuk GY, Zhang M, Wong SG, Uhanova J, Bernstein CN, Martin B, Dawood MR, Vardy L, Giulvi A. Viral hepatitis in a Canadian First Nations community. Can J Gastroenterol 2003; 17: 593-596
17. Jin A, Martin JD. Hepatitis A among residents of First Nations Reserves in British Columbia, 1991-1996. Can J Public Health 2003; 94: 176-179
18. Langer BC, Frosner GG, von Brunn A. Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland. J Viral Hepat 1997; 4: 339-349
19. McMahon BJ, Bender TR, Berquist KR, Schreeder MT, Harpster AP. Delayed development of antibody to hepatitis B surface antigen after symptomatic infection with hepatitis B virus. J Clin Microbiol 1981; 14: 130-134
20. Schreeder MT, Bender TR, McMahon BJ, Moser MR, Murphy BL, Sheller MJ, Heyward WL, Hall DB, Maynard JE. Prevalence of hepatitis B in selected Alaskan Eskimo villages. Am J Epidemiol 1983; 118: 543-549
21. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard JE. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603
22. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990; 150: 1051-1054
23. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001; 135: 759-768
24. Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snowball MM, Cagle HH, Negus SE, McMahon BJ. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 2007; 133: 1452-1457
25. Heyward WL, Lanier AP, Bender TR, Hardison HH, Dohan PH, McMahon BJ, Francis DP. Primary hepatocellular carcinoma in Alaskan natives, 1969-1979. Int J Cancer 1981; 28: 47-50
26. Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, Homan CE, Snowball MM, Cagle HH, Williams JL, Chulanov VP. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 2007; 195: 5-11
27. Popper H, Thung SN, McMahon BJ, Lanier AP, Hawkins I, Alberts SR. Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaskan Eskimos. Arch Pathol Lab Med 1988; 112: 498-504
28. Minuk GY, Nicolle LE, Postl B, Waggoner JG, Hoofnagle JH. Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population. J Med Virol 1982; 10: 255-264
29. Minuk GY, Uhanova J. Viral hepatitis in the Canadian Inuit and First Nations populations. Can J Gastroenterol 2003; 17: 707-712
30. Olsen OR, Skinhoj P, Krogsgaard K, Baek L. [Hepatitis B - an endemic sexually transmitted infection in a local community in Greenland] Ugeskr Laeger 1989; 151: 1668-1670
31. Melbye M, Skinhoj P, Nielsen NH, Vestergaard BF, Ebbesen P, Hansen JP, Biggar RJ. Virus-associated cancers in Greenland: frequent hepatitis B virus infection but low primary hepatocellular carcinoma incidence. J Natl Cancer Inst 1984; 73: 1267-1272
32. Krarup HB, Andersen S, Madsen PH, Okkels H, Hvingel BH, Laurberg P. Benign course of long-standing hepatitis B virus infection among Greenland Inuit? Scand J Gastroenterol 2008; 43: 334-343
33. McMahon BJ, Hennessy TW, Christensen C, Bruden D, Sullivan DG, Homan C, Deubner H, Bruce MG, Livingston S, Williams J, Gretch DR. Epidemiology and risk factors for hepatitis C in Alaska Natives. Hepatology 2004; 39: 325-332
34. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562
35. Dominitz JA, Boyko EJ, Koepsell TD, Heagerty PJ, Maynard C, Sporleder JL, Stenhouse A, Kling MA, Hrushesky W, Zeilman C, Sontag S, Shah N, Ona F, Anand B, Subik M, Imperiale TF, Nakhle S, Ho SB, Bini EJ, Lockhart B, Ahmad J, Sasaki A, van der Linden B, Toro D, Martinez-Souss J, Huilgol V, Eisen S, Young KA. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005; 41: 88-96
36. Neumeister AS, Pilcher LE, Erickson JM, Langley LL, Murphy MM, Haukaas NM, Mailliard ME, Larsen JL. Hepatitis-C prevalence in an urban native-American clinic: a prospective screening study. J Natl Med Assoc 2007; 99: 389-392
37. Wilson C. Hepatitis C infection and type 2 diabetes in American-Indian women. Diabetes Care 2004; 27: 2116-2119
38. Lau JY, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, Lindsay KL, Gish RG, Qian KP. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171: 281-289
39. Christensen C, Bruden D, Livingston S, Williams J, Homan C, Sullivan D, Gretch DR, McMahon BJ. Hepatitis C treatment results in an Alaska Native/American Indian population. Hepatology 2005; 42: 654A
40. Muir AJ, Bornstein JD, Killenberg PG. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med 2004; 350: 2265-2271
41. Moses S, Mestery K, Kaita KD, Minuk GY. Viral hepatitis in a Canadian street-involved population. Can J Public Health 2002; 93: 123-128
42. Scott JD, McMahon BJ, Bruden D, Sullivan D, Homan C, Christensen C, Gretch DR. High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clin Infect Dis 2006; 42: 945-952
43. Farci P. Delta hepatitis: an update. J Hepatol 2003; 39 Suppl 1: S212-S219
44. McMahon BJ. Viral hepatitis in the Arctic. Int J Circumpolar Health 2004; 63 Suppl 2: 41-48
45. Minuk GY, Sun A, Sun DF, Uhanova J, Nicolle LE, Larke B, Giulivi A. Serological evidence of hepatitis E virus infection in an indigenous North American population. Can J Gastroenterol 2007; 21: 439-442
46. Kunitz SJ, Levy JE, Everett M. Alcoholic cirrhosis among the Navaho. Q J Stud Alcohol 1969; 30: 672-685
47. Singh GK, Hoyert DL. Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption. Hum Biol 2000; 72: 801-820
48. Denny CH, Holtzman D, Cobb N. Surveillance for health behaviors of American Indians and Alaska Natives. Findings from the Behavioral Risk Factor Surveillance System, 1997-2000. MMWR Surveill Summ 2003; 52: 1-13
49. Mendenhall CL, Gartside PS, Roselle GA, Grossman CJ, Weesner RE, Chedid A. Longevity among ethnic groups in alcoholic liver disease. Alcohol Alcohol 1989; 24: 11-19
50. Saunders JB, Wodak AD, Haines A, Powell-Jackson PR, Portmann B, Davis M, Williams R. Accelerated development of alcoholic cirrhosis in patients with HLA-B8. Lancet 1982; 1: 1381-1384
51. Mao Y, Moloughney BW, Semenciw RM, Morrison HI. Indian Reserve and registered Indian mortality in Canada. Can J Public Health 1992; 83: 350-353
52. Yoshida EM, Caron NR, Buczkowski AK, Arbour LT, Scudamore CH, Steinbrecher UP, Erb SR, Chung SW. Indications for liver transplantation in British Columbia's Aboriginal population: a 10-year retrospective analysis. Can J Gastroenterol 2000; 14: 775-779
53. Lavik B, Holmegaard C, Becker U. Drinking patterns and biochemical signs of alcoholic liver disease in Danish and Greenlandic patients with alcohol addiction. Int J Circumpolar Health 2006; 65: 219-227
54. Beals J, Novins DK, Spicer P, Whitesell NR, Mitchell CM, Manson SM. Help seeking for substance use problems in two American Indian reservation populations. Psychiatr Serv 2006; 57: 512-520
55. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005
56. Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 2002; 97: 2402-2407
57. Hurlburt KJ, McMahon BJ, Gove J, Livingston S, Bulkow L, Cagle HH. Incidence and prevalence of autoimmune hepatitis in Alaska Natives. Hepatology 2006; 44: 638A
58. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99-103
59. Hurlburt KJ, McMahon BJ, Livingston S, Gove J, Cagle H. Population-based study of Alaska Native persons with autoimmune hepatitis: clinical presentation, response to treatment and relapses. Hepatology 2007; 46 Suppl 1: 558A
60. Chung H, Ho JK, Leung B, Le N, Steinbrecher U, Yoshida E. Autoimmune hepatitis referrals to the British Columbia transplant society: A disproportionate representation from BC's First Nations community. Can J Gastroenterol 2005; 19: 177
61. Riley M, Schreiber R. Immune liver disease among First Nations children in British Columbia. Can J Gastroenterol 2005; 19: 191
62. Arbour L, Rupps R, Field L, Ross P, Erikson A, Henderson H, Hill W, Yoshida E. Characteristics of primary biliary cirrhosis in British Columbia's First Nations population. Can J Gastroenterol 2005; 19: 305-310
63. Health status of American Indians compared with other racial/ethnic minority populations--selected states, 2001-2002. MMWR Morb Mortal Wkly Rep 2003; 52: 1148-1152
64. Drouin E, Russo P, Tuchweber B, Mitchell G, Rasquin-Weber A. North American Indian cirrhosis in children: a review of 30 cases. J Pediatr Gastroenterol Nutr 2000; 31: 395-404
65. Chagnon P, Michaud J, Mitchell G, Mercier J, Marion JF, Drouin E, Rasquin-Weber A, Hudson TJ, Richter A. A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis. Am J Hum Genet 2002; 71: 1443-1449
66. Nielsen IM, Ornvold K, Jacobsen BB, Ranek L. Fatal familial cholestatic syndrome in Greenland Eskimo children. Acta Paediatr Scand 1986; 75: 1010-1016
67. O'Neil J, Powell L. Clinical aspects of hemochromatosis. Semin Liver Dis 2005; 25: 381-391
68. Barton JC, Acton RT, Lovato L, Speechley MR, McLaren CE, Harris EL, Reboussin DM, Adams PC, Dawkins FW, Gordeuk VR, Walker AP. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study. Clin Genet 2006; 69: 48-57
69. Barton JC, Barton EH, Acton RT. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity. BMC Med Genet 2006; 7: 22
70. De Benedetti VM, Welsh JA, Trivers GE, Harpster A, Parkinson AJ, Lanier AP, McMahon BJ, Bennett WP. p53 is not mutated in hepatocellular carcinomas from Alaska Natives. Cancer Epidemiol Biomarkers Prev 1995; 4: 79-82
71. Statistics Canada. Age-standardized mortality rates by selected causes, by sex. Accessed Mar 1, 2008. Available from: URL: http://www40.statcan.ca/l01/cst01/health30a.htm